PBM Hearing Delayed To April 9; 4 of 5 Invitees Agree To Testify

By John Wilkerson, Rachel Cohrs  
March 19, 2019 at 4:05 PM
The Senate Finance Committee rescheduled to April 9 its upcoming hearing on the role of pharmacy benefit managers in drug price increases due to NATO Secretary General Jens Stoltenberg’s joint address to Congress on April 3, the original date for that hearing. Finance Chair Chuck Grassley said four of the five invited PBM-executive witnesses have agreed to testify, but the Iowa Republican declined to identify the hold-out. The invitees are Cigna, CVS Caremark and CVS Health, Humana, OptumRx and Prime...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.